Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
11.72
-0.23 (-1.92%)
At close: May 16, 2025, 4:00 PM
11.80
+0.08 (0.68%)
After-hours: May 16, 2025, 7:51 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $1.41 billion as of May 16, 2025. Its market cap has increased by 92.96% in one year.
Market Cap
1.41B
Enterprise Value
1.50B
1-Year Change
92.96%
Ranking
Category
Stock Price
$11.72
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $1.41B, an increase of 138.01%. That is a compound annual growth rate of 9.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 1.35B | -40.25% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |